(Q37833138)

English

Coexistence of TDP-43 and tau pathology in neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome).

scientific article published on 30 January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

Coexistence of TDP-43 and tau pathology in neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome). (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

neurodegeneration with brain iron accumulation

0 references

0 references

neurodegeneration

1 reference

based on heuristic

inferred from title

author name string

Takashi Haraguchi

1

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Seishi Terada

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Hideki Ishizu

3

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Osamu Yokota

4

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Hidenori Yoshida

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Naoya Takeda

6

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Yuki Kishimoto

7

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Naoko Katayama

8

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Hiroshi Takata

9

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Motohiro Akagi

10

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Shigetoshi Kuroda

11

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Yuetsu Ihara

12

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Yosuke Uchitomi

13

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

publication date

30 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

531-539

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Pantothenate kinase-associated neurodegeneration (Hallervorden-Spatz syndrome).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Pathogenesis of pigment and spheroid formation in Hallervorden-Spatz syndrome and related disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Widespread occurrence of alpha-synuclein/NACP-immunoreactive neuronal inclusions in juvenile and adult-onset Hallervorden-Spatz disease with Lewy bodies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Juvenile-onset generalized neuroaxonal dystrophy (Hallervorden-Spatz disease) with diffuse neurofibrillary and lewy body pathology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Widespread expression of alpha-synuclein and tau immunoreactivity in Hallervorden-Spatz syndrome with protracted clinical course

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Tau-predominant-associated pathology in a sporadic late-onset Hallervorden-Spatz syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Neuroaxonal dystrophy with neuromelanin deposition, neurofibrillary tangles, and neuronal loss. Light- and electron-microscopic changes in a 45-year-old woman with progressive psychomotor deterioration.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Adult onset Hallervorden-Spatz disease with neurofibrillary pathology. A discrete clinicopathological entity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Pallido-nigro-luysian atrophy, progressive supranuclear palsy and adult onset Hallervorden-Spatz disease: A case of akinesia as a predominant feature of parkinsonism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

The nosology of Hallervorden-spatz disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Late adult onset chorea with typical pathology of Hallervorden-Spatz syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

TDP-43 is deposited in the Guam parkinsonism-dementia complex brains.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Neuroaxonal dystrophy. A case of delayed onset and protracted course.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Iron in the Hallervorden-Spatz syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2010.01186.X

21 January 2018

Identifiers

10.1111/J.1440-1789.2010.01186.X

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

release_lydj2rswrnfsxjlsp5todnkvue

1 reference

https://api.fatcat.wiki/v0/release/lydj2rswrnfsxjlsp5todnkvue

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37833138&oldid=2165079383"